Researchers aim to refine its prototype, with plans to start clinical trials by 2026.  Read more at straitstimes.com.

Bank of New York Mellon Corp grew its stake in OrthoPediatrics Corp. (NASDAQ:KIDS – Free Report) by 3.8% in the fourth quarter, Holdings Channel reports. The fund owned 57,710 shares of the company’s ...